Attorneys general ask HHS to punish 340B program bilkers — but pharma claims it's fighting 'waste and abuse'
Imagined as a benefit for low-income patients, the government’s 340B scheme requires participating drugmakers to sell their drugs at significant discounts to play ball in Medicare and Medicaid. But some pharmas are now loudly refusing to follow the rules after citing “waste and abuse” — and state prosecutors are demanding an intervention.
In a Monday letter to HHS Secretary Alex Azar, a group of attorneys general from 28 states and the District of Columbia called on the agency to impose civil penalties on a group of Big Pharma players it claims have either stopped or plan to stop honoring discounts under the government’s 340B program.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.